OrthoPediatrics Corp. appointed Samuel Riccitelli as an independent director, effective Dec. 15.
Riccitelli's appointment brings the company's board to 11 members.
From 2012 to 2017, Riccitelli served as president, CEO and a director of Signal Genetics Inc., a molecular diagnostic company that was sold to Miragen Therapeutics Inc.
